Carisma Therapeutics
CARM
CARM
56 hedge funds and large institutions have $37.3M invested in Carisma Therapeutics in 2020 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 16 increasing their positions, 11 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
56
Holders Change
+11
Holders Change %
+24.44%
% of All Funds
0.99%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
14
Increased
16
Reduced
11
Closed
3
Calls
$80K
Puts
$174K
Net Calls
-$94K
Net Calls Change
-$689K
Top Buyers
| 1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$7.96M |
| 2 |
2
Renaissance Technologies
New York
|
$3.93M |
| 3 |
3
Millennium Management
New York
|
$860K |
| 4 |
4
Two Sigma Advisers
New York
|
$971K |
| 5 |
5
Morgan Stanley
New York
|
$2.35M |
Top Sellers
| 1 |
1
Qube Research & Technologies (QRT)
London,
United Kingdom
|
$446K |
| 2 |
2
Squarepoint
New York
|
$0 |
| 3 |
3
Goldman Sachs
New York
|
$45K |
| 4 |
4
Jane Street
New York
|
$53K |
| 5 |
5
Citadel Advisors
Miami,
Florida
|
$83K |
